Trial NCT02584634

View at ClinicalTrials.gov 
Org. Study IDs: B9991005
Secondary IDs: 2015-001879-43 JAVELIN LUNG 101

Last trial update was posted on 2023-07-07

MeSH Interventions

Avelumab Crizotinib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-Small Cell Lung Cancer

Stopping Reasons

The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the Investigational treatments have been moved to a continuation study (NCT05059522)

Limitations And Caveats

Enrollment in the study was terminated early based on the changing landscape in treatment options for treatment naïve ALK positive NSCLC. This decision was not due to any safety concerns or regulatory interactions. All participants on active treatment at the time of the early enrollment termination could continue treatment and follow up per the protocol.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID